Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Looking for the latest stock opportunities in August 2026? We have you covered. Click to read our top stock picks to consider ...

On July 6, BioPharma Dive reported that drug developers producing new medicines for the treatment of autoimmune disorders and ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.

Biotechnology companies are coming out of a dark period for the industry. Why has the tide turned and is now a good time to ...

It's been a volatile year for the company, but don't let that scare you away.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best biotech stocks on this list. TheFly reported on June 10 that UBS increased its price target on CLDX to $45 from $38 while maintaining a Buy ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the questions I get more than any other is, “Jonathan, how do you ...

IBBQ's concentrated biotech play has delivered a higher one-year return, while IXJ'S diversified global healthcare fund has been much less volatile.

Biotech stock Arcutis is in a buy zone and Wall Street is looking for the skin-diseases drugmaker to expand the use of its ...

CRISPR Therapeutics is a gene editing specialist. It developed Casgevy, a medicine for two rare blood diseases, in collaboration with Vertex Pharmaceuticals. Casgevy doesn't generate much revenue yet, ...